Insilico Medicine joins HKEX Tech 100
Analysis based on 6 articles · First reported Jul 20, 2026 · Last updated Sep 03, 2026
The inclusion is expected to boost Insilico Medicine's stock liquidity and attract passive fund inflows, potentially supporting its share price. It also signals growing investor interest in AI-driven drug discovery, which may positively affect the broader biotech and AI sectors.
Insilico Medicine, a clinical-stage drug discovery company powered by generative AI, announced its inclusion in the HKEX Tech 100 Index. The inclusion follows methodology enhancements announced on 18 August 2026 to broaden exposure to emerging technology trends, including AI value chain opportunities. The changes will be implemented after market close on 11 September 2026 and take effect on 14 September 2026. The HKEX Tech 100 Index tracks 100 of the largest Hong Kong-listed companies with high exposure to key tech themes and is eligible for Southbound Stock Connect. For Insilico, inclusion validates its AI technology capabilities and is expected to enhance trading liquidity, expand capital access, and attract inflows from index-tracking passive funds and Mainland Chinese investors. The company has previously been included in several major index series, including MSCI Global Small Cap, Hang Seng Healthcare, Hang Seng Biotechnology, and FTSE Global indexes. Insilico recently reported total revenue of approximately $106 million in the first half of 2026, a 287% year-over-year increase, and achieved its first profitable half-year since listing with adjusted net profit exceeding $51 million. This milestone was driven by collaborations with partners such as Eli Lilly, Laboratoires Servier, Takeda, SK Biopharmaceuticals, and Qilu Pharmaceutical. The company also nominated nine development candidates within nine months of 2026 and advanced Rentosertib, the world's first generative AI-discovered drug candidate, to a Phase III trial for idiopathic pulmonary fibrosis.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard